Recombinant Schizosaccharomyces pombe A1 cistron-splicing factor aar2 (aar2)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Schizosaccharomyces pombe A1 Cistron-Splicing Factor Aar2 (Aar2)

Recombinant Schizosaccharomyces pombe A1 cistron-splicing factor Aar2, commonly referred to as Aar2, is a protein involved in the splicing of pre-mRNA in the fission yeast Schizosaccharomyces pombe . Specifically, Aar2 plays a crucial role in the removal of introns from mRNA precursors, a process essential for gene expression .

Aar2 and the Spliceosome

Aar2 is a component of the U5 snRNP complex, which is essential for spliceosome assembly and pre-mRNA splicing . The spliceosome is composed of numerous proteins, and studies have focused on identifying proteins associated with splicing factors such as Ntr1, Ntr2, Brr2, and Gpl1 to further understand the protein interaction network of the spliceosome .

Impact of Aar2 Dysfunction

Disruption or mutation of Aar2 leads to several observable defects:

  • Splicing Defects: The aar2 mutant and disruptant show a defect in splicing two short introns of the a1 pre-mRNA .

  • Mating Type Defects: Cells of the aar2 mutant and the aar2 disruptant contain alpha 1 and alpha 2 transcripts but their a1 transcript migrates more slowly than that of the wild-type cells and gives a diffused band .

  • Growth Defects: Cells of the aar2 mutant and disruptant show a growth defect .

Interaction with Other Proteins

Research has shown that proteins like Nrl1 (NRDE-2 like 1) interact with spliceosome proteins, influencing pre-mRNA splicing . Identifying proteins associated with splicing factors provides insights into the protein interaction network of the spliceosome .

Relevance to Genome Stability

The spliceosome, including factors like Aar2, plays a role in maintaining genome stability . Nrl1 regulates pre-mRNA splicing and homologous recombination-dependent R-loop formation, suggesting a link between splicing factors and genome stability .

AAR2 Reagents

A variety of reagents are available for studying AAR2 in different species:

AAR2 Antibodies for Saccharomyces cerevisiae

CodeProduct NameSpecies ReactivityApplication
CSB-PA333689XA01SVGAAR2 AntibodySaccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)ELISA, WB (ensure identification of antigen)

AAR2 Antibodies for Schizosaccharomyces pombe

CodeProduct NameSpecies ReactivityApplication
CSB-PA747028XA01SXVaar2 AntibodySchizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)ELISA, WB (ensure identification of antigen)

AAR2 Proteins for Saccharomyces cerevisiae

CodeProduct NameSource
CSB-YP333689SVGRecombinant Saccharomyces cerevisiae A1 cistron-splicing factor AAR2 (AAR2)Yeast
CSB-EP333689SVGRecombinant Saccharomyces cerevisiae A1 cistron-splicing factor AAR2 (AAR2)E.coli
CSB-BP333689SVGRecombinant Saccharomyces cerevisiae A1 cistron-splicing factor AAR2 (AAR2)Baculovirus
CSB-MP333689SVGRecombinant Saccharomyces cerevisiae A1 cistron-splicing factor AAR2 (AAR2)Mammalian cell
CSB-EP333689SVG-BRecombinant Saccharomyces cerevisiae A1 cistron-splicing factor AAR2 (AAR2)In Vivo Biotinylation in E.coli

Product Specs

Form
Lyophilized powder Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on purchasing method and location. Contact your local distributor for precise delivery estimates. Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, serving as a guideline for customers.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. The tag type is determined during the production process. Please specify your desired tag type for preferential development.
Synonyms
aar2; SPAC3H5.04A1 cistron-splicing factor aar2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-346
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
Target Names
Target Protein Sequence
MSIEFVGWLN TYYVGIDQSS YEASKLPGIR NVKGGIHLFT WSPTYPAGLI SGVFAMVHED MKYSIDFDSK SETASLQKLD VLYDENFYPF ESTKDWDLLT KFITVQDLQR IFATEGEFFY LDTSTYVNAD LVSQDPEFSK PSRDDKLLNF AEFNLRRSWS PSATGPERSK QAIDKSFLFQ RLVQSVWNDN PISALAELSI SFLSYSILSH YGALEHWKNM LSLLLQSYEL AETEPEFYAS FLELFKLQLS SLSESDLETS AIFEKGVLLS CLDSLSERKV DGSFGSLVNE AIENLLKTIS ELLNSHEEQA GLMQKGDLYS AADYEAEVHE TGDYVIDVST EEDPIH
Uniprot No.

Target Background

Function
A component of the U5 snRNP complex essential for spliceosome assembly and pre-mRNA splicing. It plays a role in splicing pre-mRNA of the A1 cistron and other genes crucial for cell growth.
Database Links
Protein Families
AAR2 family
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is the S. pombe AAR2 protein and what is its primary function?

AAR2 is a conserved splicing factor in eukaryotes that plays a critical role in pre-mRNA processing. In Schizosaccharomyces pombe (fission yeast), as in other eukaryotes, AAR2 functions primarily as a U5 snRNP assembly factor essential for pre-mRNA splicing. The protein participates in the removal of introns from pre-mRNA transcripts, contributing to proper gene expression and protein synthesis. Research in other model organisms like yeast and humans has confirmed AAR2's global impact on pre-mRNA splicing through its role in U5 snRNP assembly . In Arabidopsis, beyond its conserved splicing function, AAR2 has also been shown to promote microRNA accumulation, suggesting potential additional roles that may also exist in S. pombe .

How does S. pombe AAR2 compare to its homologs in other organisms?

S. pombe AAR2 shares functional homology with AAR2 proteins found in other eukaryotes like Saccharomyces cerevisiae (budding yeast), mammals, and plants. All AAR2 homologs participate in U5 snRNP assembly for pre-mRNA splicing, indicating a highly conserved function across evolutionary lineages. In Arabidopsis, research has shown that AAR2 has expanded functionality, promoting microRNA biogenesis in addition to pre-mRNA splicing . Specifically, Arabidopsis AAR2 interacts with the microprocessor component HYL1 and promotes its dephosphorylation to produce the active form required for miRNA biogenesis . This suggests potential expanded roles for AAR2 in S. pombe that warrant further investigation, particularly regarding possible interactions with RNA processing pathways beyond canonical splicing.

What phenotypes are associated with aar2 mutations or deletions in S. pombe?

Based on studies in related organisms, aar2 mutations in S. pombe would likely result in global splicing defects affecting hundreds to thousands of introns. In Arabidopsis, aar2 mutants exhibit significant intron retention events, with specific mutations (aar2-1 and aar2-2) showing 512 and 1,159 intron retention events respectively . By extension, S. pombe aar2 mutants would likely demonstrate broad splicing dysregulation affecting multiple cellular processes. The precise phenotypes would depend on which genes are most affected by splicing disruption, but could include growth defects, stress response abnormalities, and cell cycle irregularities. RNA-seq analysis in S. pombe aar2 mutants, similar to what has been performed in Arabidopsis, would help identify the specific transcripts and biological processes most affected by AAR2 deficiency.

What expression systems are most effective for producing recombinant S. pombe AAR2 protein?

For recombinant expression of S. pombe AAR2, several systems can be considered based on the experimental goals. For high-yield protein production, E. coli expression systems using vectors like pET or pGEX offer robust expression, though proper folding of eukaryotic proteins can be challenging. Yeast expression systems provide an attractive alternative, particularly for functional studies. Drawing parallels from the expression system developed for the human beta 2-adrenergic receptor in S. pombe, a similar approach could be adapted for AAR2 . This would involve cloning the aar2 gene under the control of a constitutive promoter such as the S. pombe alcohol dehydrogenase (adh) promoter . For mammalian expression, vectors like pcDNA can be employed when studying interactions with mammalian proteins. The choice ultimately depends on whether the goal is structural studies, functional characterization, or interaction analysis.

How can I design experiments to study the interaction between AAR2 and the splicing machinery in S. pombe?

To investigate AAR2's interactions with the splicing machinery, multiple complementary approaches should be employed. Co-immunoprecipitation (Co-IP) experiments using epitope-tagged AAR2 expressed in S. pombe can identify direct protein-protein interactions with components of the spliceosome, particularly the U5 snRNP complex. Crosslinking and immunoprecipitation (CLIP) assays would reveal RNA binding profiles and preferences of AAR2. Yeast two-hybrid screening could uncover novel protein interactions, while in vitro binding assays with purified components would confirm direct interactions. For functional studies, RNA-seq analysis comparing wild-type and aar2 mutant strains would identify specific splicing events dependent on AAR2. Additionally, spliceosome assembly assays using in vitro transcribed pre-mRNAs and S. pombe extracts can determine at which stage of spliceosome assembly AAR2 functions, similar to approaches used in studies of other splicing factors in yeast and Arabidopsis .

What techniques are recommended for analyzing global splicing changes in aar2 mutants?

For comprehensive analysis of splicing alterations in aar2 mutants, RNA sequencing (RNA-seq) with sufficient read depth (>30 million paired-end reads per sample) is the gold standard. Analysis should utilize specialized algorithms designed to detect alternative splicing events, such as rMATS, MAJIQ, or SUPPA2. Based on approaches used in Arabidopsis aar2 studies, experiments should include at least three biological replicates of wild-type and mutant strains grown under identical conditions . Beyond computational analysis, validation of key splicing events should be performed using RT-PCR with primers spanning exon-exon junctions. For quantitative analysis of specific events, quantitative RT-PCR can be employed. Splicing reporter constructs carrying selected introns inserted into a fluorescent protein coding sequence can provide visual confirmation of splicing defects. Additionally, spliceosome profiling using gradient fractionation followed by RNA-seq of associated RNAs can reveal which steps of splicing are affected, as previously applied in studies of other splicing factors .

How does AAR2 specificity for certain pre-mRNAs arise in S. pombe?

The specificity of AAR2 for certain pre-mRNAs likely emerges from a combination of factors including pre-mRNA sequence features, secondary structures, and interactions with other splicing regulators. From studies in Arabidopsis, we know that genes with more introns tend to be more affected by aar2 mutations, suggesting intron complexity as one determinant of AAR2 dependency . RNA secondary structures, particularly double-stranded RNA (dsRNA) regions containing GA-rich sequences, may play a crucial role in AAR2 substrate recognition, similar to how ADARs interact with splicing machinery . Additionally, AAR2 may preferentially affect pre-mRNAs with specific splicing regulatory elements like GA-rich sequences or particular polypyrimidine tract characteristics. To comprehensively address this question, researchers should conduct RNA immunoprecipitation followed by sequencing (RIP-seq) or CLIP-seq experiments with tagged AAR2 to identify binding sites, coupled with motif analysis and RNA structure prediction to determine sequence and structural preferences that drive specificity.

What is the role of AAR2 in the coordination between pre-mRNA splicing and other RNA processing events?

AAR2 likely functions as a bridge between splicing and other RNA processing pathways, similar to its role in Arabidopsis where it influences both splicing and microRNA processing . In S. pombe, AAR2 may coordinate splicing with transcription, RNA export, nonsense-mediated decay, or RNA editing. The physical association of splicing factors like Rtf2 with RNA processing machineries in S. pombe suggests potential coordination between these processes . To investigate this coordination, researchers should perform proteomics analyses of AAR2-associated complexes under various cellular conditions, examine the effects of aar2 mutations on transcription rates and RNA export efficiency, and analyze the co-localization of AAR2 with components of different RNA processing pathways using fluorescence microscopy. Additionally, studying the effects of aar2 mutations on transcriptome-wide RNA stability and turnover would reveal connections to RNA quality control pathways. The potential interaction between AAR2 and RNA editing factors should be examined through co-immunoprecipitation and functional assays, drawing insights from known interactions between RNA editing enzymes and splicing machineries .

How does post-translational modification of AAR2 regulate its splicing activity in S. pombe?

Post-translational modifications (PTMs) of AAR2 likely serve as regulatory switches controlling its activity, localization, and interactions. While specific PTMs of S. pombe AAR2 have not been extensively characterized, research on splicing factors in other organisms suggests potential regulatory mechanisms. Phosphorylation is likely to be a key regulatory modification, potentially affecting AAR2's ability to associate with the U5 snRNP or other spliceosome components. To investigate this question, researchers should employ mass spectrometry to identify PTMs on AAR2 purified from S. pombe cells under different conditions (e.g., normal growth, stress, cell cycle stages). Mutational analysis converting modified residues to non-modifiable amino acids (phosphomimetic or non-phosphorylatable) would help determine the functional significance of identified PTMs. Kinase and phosphatase inhibitor studies could reveal the enzymes responsible for AAR2 modifications. Additionally, comparing the interactome of wild-type AAR2 versus PTM-deficient mutants would clarify how modifications affect protein-protein interactions and integration into splicing complexes.

What are the optimal conditions for analyzing AAR2-dependent splicing events in vitro?

For robust in vitro analysis of AAR2-dependent splicing, the preparation of functional S. pombe nuclear or whole-cell extracts is critical. The extract should maintain splicing competence, which can be verified using model pre-mRNA substrates. Based on methodologies used for studying other splicing factors, the optimal reaction conditions would typically include: 3-5 mM MgCl₂, 50-100 mM KCl, 1-2 mM ATP, 5-10 mM creatine phosphate, 2-3% polyvinyl alcohol, and a buffering system maintaining pH 7.4-7.6 . Pre-mRNA substrates should be transcribed in vitro using T7 or SP6 RNA polymerase and labeled with ³²P for detection or fluorescent tags for FRET-based analyses. For depletion and reconstitution experiments, the extract can be immunodepleted of endogenous AAR2 using specific antibodies, followed by supplementation with recombinant wild-type or mutant AAR2 proteins. Temperature optimization is crucial, with reactions typically performed at 25-30°C for S. pombe extracts. Time-course experiments (10-180 minutes) should be conducted to determine the kinetics of AAR2-dependent splicing events compared to AAR2-independent reactions.

How can I design RNA-seq experiments to effectively capture AAR2-dependent splicing changes?

An effective RNA-seq experimental design for capturing AAR2-dependent splicing changes requires careful consideration of multiple factors. Based on approaches used in Arabidopsis AAR2 studies, the experimental design should include:

ParameterRecommendationRationale
Read typePaired-end, 150bpEnables detection of exon junctions and complex splicing events
Sequencing depth>30 million reads/sampleEnsures sufficient coverage of low-abundance transcripts
ReplicationMinimum 3 biological replicatesProvides statistical power to detect significant changes
ControlsWild-type, aar2 mutant, aar2 rescueAllows confirmation of AAR2-specific effects
RNA isolationTRIzol followed by poly(A) selectionEnriches for mRNAs while preserving splicing intermediates
Library preparationStrand-specific protocolsDistinguishes sense and antisense transcription

Analysis should utilize specialized pipelines for splicing detection (e.g., rMATS, SUPPA2) with particular attention to intron retention events, which were prominent in Arabidopsis aar2 mutants . Including spike-in controls allows normalization across samples. For validation, RT-PCR should be performed on at least 10-15 candidate events spanning different types of splicing changes. Additionally, comparing results to publicly available data from other splicing factor mutants would highlight AAR2-specific patterns versus general splicing disruption signatures .

What approaches can be used to study the integration of AAR2 into spliceosomal complexes?

To investigate AAR2's integration into spliceosomal complexes, researchers should employ a multi-faceted approach. Glycerol gradient sedimentation or native gel electrophoresis can separate distinct spliceosomal complexes (E, A, B, C), followed by western blotting to detect AAR2. For dynamic association studies, splicing can be synchronized using ATP depletion/repletion or temperature-sensitive mutants, and AAR2's presence in different complexes can be tracked over time. Electron microscopy or cryo-EM of purified complexes containing tagged AAR2 would provide structural insights into its position within the spliceosome. For interaction mapping, chemical crosslinking followed by mass spectrometry (XL-MS) can identify AAR2's neighboring proteins within the complex. To identify AAR2's role in U5 snRNP assembly specifically, researchers should compare U5 snRNP composition in wild-type and aar2 mutant cells using immunoprecipitation of U5 snRNA or U5-specific proteins like Prp8, followed by mass spectrometry to identify proteins whose association depends on AAR2. Additionally, in vitro U5 snRNP assembly assays using recombinant components would reveal the precise stage at which AAR2 functions, similar to approaches used in studies of U5 snRNP assembly factors in other organisms .

How should I interpret conflicting results between in vitro and in vivo studies of AAR2 function?

Conflicting results between in vitro and in vivo studies of AAR2 often reflect the complex regulatory environment inside cells that cannot be fully recapitulated in vitro. When facing such discrepancies, first examine the experimental conditions of both approaches. In vitro studies may lack critical co-factors, post-translational modifications, or proper protein concentrations required for physiological AAR2 function. Conversely, in vivo studies may reveal indirect effects resulting from cellular adaptations to AAR2 perturbation rather than direct AAR2 functions. To resolve these conflicts, perform intermediate complexity experiments such as splicing assays in semi-intact cells or using nuclear/whole-cell extracts that maintain more physiological conditions than purely recombinant systems . Additionally, structure-function analyses using AAR2 mutants designed to disrupt specific interactions or activities can help determine which aspects of AAR2 function are direct versus indirect. Consider using rapid induction or depletion systems (e.g., auxin-inducible degron tags) to distinguish immediate versus adaptive effects of AAR2 perturbation. Finally, computational modeling integrating both in vitro kinetic data and in vivo network effects can help reconcile seemingly contradictory observations by placing them in a broader systems biology context.

What statistical approaches are most appropriate for analyzing differential splicing in aar2 mutants?

For robust statistical analysis of differential splicing in aar2 mutants, multiple complementary approaches should be employed. Based on methodologies used in similar studies, the following statistical framework is recommended:

Analysis TypeRecommended MethodApplication
Differential exon usageDEXSeq or limma/diffSpliceIdentifies individual exons with altered inclusion
Percent spliced in (PSI)rMATS or SUPPA2Quantifies splicing event frequencies
Splicing event detectionLeafCutter or MAJIQDiscovers novel splicing events
Intron retention analysisIRFinderSpecifically targets intron retention events
Multiple testing correctionBenjamini-Hochberg FDRControls false discovery while maintaining sensitivity

Statistical significance thresholds should include both p-value (<0.05) and effect size criteria (e.g., |ΔPSI| > 0.1). For more complex splicing patterns, mixture models can account for heterogeneity within samples. Gene Ontology enrichment analysis of differentially spliced genes helps identify biological processes affected by AAR2 deficiency. When comparing results to other splicing factor mutants, hierarchical clustering or principal component analysis of splicing profiles can position AAR2 within the broader splicing regulatory network. Finally, permutation tests comparing observed splicing changes to random expectations can identify sequence or structural features significantly associated with AAR2-dependent splicing .

How can I distinguish direct effects of AAR2 from indirect consequences of splicing dysregulation?

Distinguishing direct from indirect effects of AAR2 requires a multi-layered experimental approach. The most definitive method is to perform AAR2 CLIP-seq or similar binding assays to identify the direct RNA targets of AAR2, which can then be compared with transcripts showing splicing changes in aar2 mutants . Rapid depletion systems (e.g., auxin-inducible degron) allow time-course studies that can separate immediate (likely direct) effects from later (potentially indirect) consequences. In vitro splicing assays with purified components can confirm direct AAR2 requirements for specific splicing events. Computational approaches can help by identifying sequence or structural motifs enriched in directly affected transcripts. Rescue experiments using structure-guided AAR2 mutants that disrupt specific interactions while preserving others can disentangle different aspects of AAR2 function. Additionally, comparing the splicing profile of aar2 mutants with other splicing factor mutants can identify unique signatures of direct AAR2 action versus general splicing disruption, as was done in Arabidopsis by comparing aar2 mutants with mac3a mac3b or prl1 prl2 mutants . Finally, integrating transcriptome data with proteome analysis can determine which splicing changes ultimately affect protein expression, helping prioritize functionally significant direct targets.

How can computational modeling advance our understanding of AAR2's role in splicing regulation?

Computational modeling offers powerful approaches for understanding AAR2's complex role in splicing regulation. Machine learning algorithms can integrate diverse datasets (CLIP-seq, RNA-seq, proteomics) to predict which pre-mRNAs are most dependent on AAR2 for proper splicing, based on sequence features, RNA secondary structure, and other parameters . Network analysis can position AAR2 within the broader splicing regulatory network, identifying key interaction partners and regulatory relationships. Molecular dynamics simulations using available structural data from homologous proteins can model AAR2's interactions with RNA and protein components of the spliceosome, generating testable hypotheses about binding interfaces and conformational changes. Additionally, kinetic modeling of spliceosome assembly and catalysis can determine rate-limiting steps affected by AAR2. Systems biology approaches integrating transcriptome, proteome, and interactome data can reveal emergent properties of AAR2-regulated splicing networks. For practical applications, developing computational pipelines specifically optimized for detecting AAR2-dependent splicing events would facilitate more efficient analysis of experimental data. Finally, evolutionary models comparing AAR2 across species can identify conserved versus species-specific functions, providing insights into the fundamental versus adaptable aspects of AAR2-mediated splicing regulation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.